-ADiN.jpg&w=347&h=240&crop-to-fit)
EY Entrepreneur Of The Year Singapore 2021 overall winner
Founded in 2014, MiRXES is a global leading developer of RNA-powered tests for disease early detection, with strong pipelines in multiple cancer types, as well as in cardiovascular, metabolic, and infectious diseases. MiRXES is headquartered in Singapore, with operations in China, Japanm and the United States, as well as commercial activities in over 45 countries. In 2019, MiRXES launched GASTROClear, the world’s first microRNA blood test for early detection of gastric cancer. The MiRXES’s multi-cancer early detection pipeline includes screening tests for lung, colorectal, liver, and breast cancer. In response to the Covid-19 pandemic in 2020, MiRXES worked closely with A*STAR, Diagnostics Development Hub (DxD) and Tan Tock Seng Hospital (TTSH) to mass produce Fortitude Kit, Singapore’s first authorised COVID-19 RT-PCR test.
Dr. Zhou, Dr. Zou, and Mr.Ho, who were also named EY Entrepreneur Of The Year – Biotechnology, will be Singapore’s representative to the prestigious EY World Entrepreneur Of The Year (WEOY) to be held in June 2022. They will compete with contenders from over 60 other countries for the coveted world title.
Dr. Zhou Lihan from MiRXES
EY Entrepreneur Of The Year 2021 winners with guest-of-honor, Indranee Rajah
Back
